Applied Therapeutics is making changes to its leadership less than a month after the FDA rejected its rare disease drug.
Shoshana Shendelman is stepping down …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without immunosuppression. The company’s engineered cell product (UP421) uses
Cells contain various specialized structures – such as the nucleus, mitochondria or peroxisomes – known as “organelles”.
The shortage of the diabetes and obesity injectable tirzepatide (Mounjaro, Zepbound) has been resolved, the FDA announced Thursday. As a result, compounders will have a